📰 $CRSP 🔸 FDA Approves Vertex Pharmaceuticals and Crispr Therapeutics’ Casgevy for Sickle-Cell Disease — WSJ 🔸 Casgevy Is the First Approved Treatment Using Crispr Gene-Editing Technology — WSJ 🔸 Casgevy Helped Stop Nearly All Pain Crises from Sickle-Cell Disease in a Study… https://t.co/unrAWShv08